期刊文献+

糖尿病乳酸酸中毒患者检测同型半胱氨酸的意义

Significance on Analysis Homocysteine in Diabetic Lactate Acidosis
下载PDF
导出
摘要 目的研究糖尿病乳酸酸中毒患者检测同型半胱氨酸的意义。方法选取100例T2DM患者,其中60例服用双胍类降糖药物,另择100例健康人作为对照组。血气动脉血检测两组的血乳酸(Lac),透射比浊法检测糖化血红蛋白(HbAlc),酶法检测肌酐(Cr)、尿素氮(BUN)和同型半胱氨酸(Hcy),数据进行相关的统计学分析。结果服用双胍类降糖药物的糖尿病患者乳酸水平比未服用此类药物的患者明显升高,两者差异有统计学意义(t=12.374,P〈0.01);服用双胍类降糖药物的糖尿病患者与未服用双胍类降糖药物的患者,以及对照组的Cr,BUN和Hcy值比较差异有统计学意义(P〈O.01);未服用双胍类降糖药物的患者(B组)Hcy值和对照组比较无显著性差异(t=0.648,P〉0.05)。结论高同型半胱氨酸血症是糖尿病乳酸酸中毒的一个重要危险因素。 Objective Significance on analysis homocysteine in Diabetic lactate acidosis. Methods Choiced 60 patients with DM administered Metformin and 100 cases as control group. The lactic acid of artery blood was detected by blood gas analy- sis. HbAlc,Hcy,BUN and Cr were detected by the standard method. Results Patients with administered Metformin had higher level of lactate than those with no administered Metformin (t= 12. 374, P〈0.01). The difference of Hcy, BUN and Cr was significant among patients with or no administered Metformin and control group (P〈0. 01), and Hcy has no differ- ence between no administered Metformin and control group ( t=0. 648, P〉0. 05). Conclusion Hcy was an independent risk factor in Diabetic lactate acidosis.
出处 《现代检验医学杂志》 CAS 2012年第4期117-118,共2页 Journal of Modern Laboratory Medicine
关键词 同型半胱氨酸 糖尿病 乳酸酸中毒 homocysteine diabetic lactate acidosis
  • 相关文献

参考文献4

二级参考文献32

  • 1郭永和,张维君,周玉杰,赵冬,周志明,张红.冠状动脉造影患者心血管病危险因素与冠状动脉病变程度的相关性分析[J].中华心血管病杂志,2005,33(5):415-418. 被引量:73
  • 2颜秉菊,蔡久英.高尿酸血症与冠心病及其危险因素的研究进展[J].医学综述,2006,12(14):854-856. 被引量:24
  • 3Ozkan Y,Ozkan E,Simsek B.Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease[J].Int J Cardiol,2002,83(8):267-277.
  • 4Niskanen LK,Laaksonen DN,Nyyssonen K,et al.Uric acid level as a risk factor for cardiovascular and all cause cortality in middle-aged men:a prospective cohort study.Arch k ntern Med,2004,164(4):1546-1551.
  • 5Maekawa K,Sudoh T,Fumsawa M,et al. Cloning and sequence a- nalysis o{ cDNA encoding a precursor for porcine brain natrinretic peptide[J]. Biochem Biophys Res Commun, 1988,157 (1):410 - ~16.
  • 6Asada J, Tsuji H, Thomas JD, et al. Usefulness of plasma brain natri- uretic peptide levels in predicting doubutamine - induced ischemia[J]. Am J Cardiol,2004,93(6)~ 702- 704.
  • 7Burley DS, Baxter GF. B - type natriuretie peptide limits reperfu- sion injury via opening of ATP -sensitive potassium channels[J]. J Mol Cell Cardiol,2006,40(6) :967 - 968.
  • 8Harold L, Lazar, Yusheng B, et al. Nesiritide enhances myocardial protection during the revascularization of acutely ischemic myocar- dium[J]. Cardiac Surgery,g009,24(5) :600 - 605.
  • 9Yiguo S, Yun Z, Ming Y, et al. B - Type natriuretic peptide induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition[J]. Biologieal~ Pharma-ceutical Bullietin,2009,32(9) :1545 - 1551.
  • 10Mekontso - Dessap A,Tual L,Kirsch M,et al. B - type natriuretic peptide to assess haemodynamic status after cardiac surgery[J]. British J Anaesthesia, 2006,97, (6) : 777 - 782.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部